Compare Sana Biotechnology Inc (SANA) vs Unilever plc (UL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Sana Biotechnology Inc vs Unilever plc — how do they compare? Sana Biotechnology Inc trades at $3.17 (market cap $873.84M), while Unilever plc trades at $62.18 (market cap $131.86B). The key difference: Unilever plc is far larger — about 150.9× Sana Biotechnology Inc's market cap, and Unilever plc pays a 3.68% dividend while Sana Biotechnology Inc pays none. Which is the better fit depends on your goals.
| SANA | UL | |
|---|---|---|
Market Cap | $873.84M | $131.86B |
Sector | Health | Consumer Staples |
52-Week High | $5.92 | $74.59 |
52-Week Low | $2.68 | $55.05 |
Enterprise Value | $848.03M | $157.31B |
Dividend Yield | — | 3.68% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Sana Biotechnology Inc
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →About Unilever plc
Unilever is a diversified personal product (42% of 2021 sales by value), home care (20%), and packaged food (38%) company. Its brands include Knorr soups and sauces, Hellmann's mayonnaise, Lipton teas, Axe and Dove skin products, and the TRESemme haircare brand. The firm has been acquisitive in recent years
Read more on UL →
